1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Dysgeusia (Taste Disorders) Global Clinical Trials Review, H1, 2014

Dysgeusia (Taste Disorders) Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Dysgeusia (Taste Disorders) Global Clinical Trials Review, H1, 2014" provides data on the Dysgeusia (Taste Disorders) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dysgeusia (Taste Disorders). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dysgeusia (Taste Disorders). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Dysgeusia (Taste Disorders) Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Dysgeusia (Taste Disorders) 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Dysgeusia (Taste Disorders) to Central Nervous System Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Dysgeusia (Taste Disorders) to Central Nervous System Clinical Trials 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Prominent Drugs 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Companies 24
Zeria Pharmaceutical Co Ltd 24
Clinical Trial Overview of Zeria Pharmaceutical Co Ltd 24
Clinical Trial Overview of Top Institutes / Government 25
University Hospital Basel 25
Clinical Trial Overview of University Hospital Basel 25
Comprehensive Cancer Center of Wake Forest University 26
Clinical Trial Overview of Comprehensive Cancer Center of Wake Forest University 26
Instituto Nacional de Cancerologia 27
Clinical Trial Overview of Instituto Nacional de Cancerologia 27
Charite - Universitatsmedizin Berlin 28
Clinical Trial Overview of Charite - Universitatsmedizin Berlin 28
Alberta Health Services 29
Clinical Trial Overview of Alberta Health Services 29
Uppsala University 30
Clinical Trial Overview of Uppsala University 30
Cantonal Hospital 31
Clinical Trial Overview of Cantonal Hospital 31
North Central Cancer Treatment Group 32
Clinical Trial Overview of North Central Cancer Treatment Group 32
University of Copenhagen 33
Clinical Trial Overview of University of Copenhagen 33
National Institute on Deafness and Other Communication Disorders 34
Clinical Trial Overview of National Institute on Deafness and Other Communication Disorders 34
Five Key Clinical Profiles 35
Appendix 52
Abbreviations 52
Definitions 52
Research Methodology 53
Secondary Research 53
About GlobalData 54
Contact Us 54
Disclaimer 54
Source 54

List of Tables
Dysgeusia (Taste Disorders) Therapeutics, Global, Clinical Trials by Region, 2014* 6
Dysgeusia (Taste Disorders) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Dysgeusia (Taste Disorders) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Dysgeusia (Taste Disorders) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 12
Dysgeusia (Taste Disorders) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Dysgeusia (Taste Disorders) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Dysgeusia (Taste Disorders) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 15
Dysgeusia (Taste Disorders) Therapeutics, Global, Clinical Trials by Phase, 2014* 16
Dysgeusia (Taste Disorders) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17
Dysgeusia (Taste Disorders) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Dysgeusia (Taste Disorders) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 21
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 23
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials Market, Global, Clinical Trials by Zeria Pharmaceutical Co Ltd, 2014* 24
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014* 25
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials Market, Global, Clinical Trials by Comprehensive Cancer Center of Wake Forest University, 2014* 26
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials Market, Global, Clinical Trials by Instituto Nacional de Cancerologia, 2014* 27
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2014* 28
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Health Services, 2014* 29
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials Market, Global, Clinical Trials by Uppsala University, 2014* 30
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cantonal Hospital, 2014* 31
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Treatment Group, 2014* 32
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Copenhagen, 2014* 33
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Deafness and Other Communication Disorders, 2014* 34

List of Figures
Dysgeusia (Taste Disorders) Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Dysgeusia (Taste Disorders) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Dysgeusia (Taste Disorders) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Dysgeusia (Taste Disorders) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 12
Dysgeusia (Taste Disorders) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Dysgeusia (Taste Disorders) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Dysgeusia (Taste Disorders) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 15
Dysgeusia (Taste Disorders) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16
Dysgeusia (Taste Disorders) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 17
Dysgeusia (Taste Disorders) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Dysgeusia (Taste Disorders) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 21
Dysgeusia (Taste Disorders) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 23
GlobalData Methodology 53

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.